Clinical Study


Superselective adrenal artery embolization (SAAE) has been used as a minimally invasive alternative for the treatment of adrenal tumors. The clinical efficacy of SAAE has been proved by a number of clinical studies. Since the efficacy and safety of SAAE was justified by the treatment of adrenal tumors and APA, we hypothesized that SAAE might cause a significant reduction of blood pressure in cases of hypertension caused by bilateral IHA. Here, we intend to conduct a prospective cohort study to demonstrate the efficacy and safety of SAAE for bilateral IHA with a one-month follow-up.

Study Name: Efficacy and Safety of Percutaneous Superselective Adrenal Arterial Embolization in the Treatment of Primary Aldosteronism With Bilateral Idiopathic Hyperaldosteronism: A Prospective Cohort Study
Status: Not yet recruiting
Conditions: Primary aldosteronism due to adrenal hyperplasia (bilateral)
Interventions: Procedure: superselective adrenal arterial embolization
Locations: Second Affiliated Hospital of Nanchang University, Nanchang, China
Study link:

To search for other studies by topic, location, or status, go to our Clinical Studies page.